TREATMENT OF REFRACTORY SOLID TUMORS WITH HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANT

被引：0
|
作者：
GRAHAM, ML [1 ]
YEAGER, AM [1 ]
BRAINE, HG [1 ]
SARAL, R [1 ]
SANTOS, GW [1 ]
机构：
[1] JOHNS HOPKINS UNIV HOSP,CTR ONCOL,BALTIMORE,MD 21205
来源：
EXPERIMENTAL HEMATOLOGY | 1987年 / 15卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：616 / 616
页数：1
相关论文
共 50 条
  • [31] THE EFFECT OF HIGH-DOSE CHEMOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANT IN POOR PROGNOSTIC NONSEMINOMATOUS GERMINAL TUMORS - RESULTS OF A CISPLATINUM, ETOPOSIDE AND CYCLOPHOSPHAMIDE ASSOCIATION (PEC PROTOCOL)
    BAUME, D
    PICO, JL
    DROZ, JP
    OSTRONOFF, M
    AZAB, M
    GILLES, E
    GHOSN, M
    SALLOUM, E
    GOUYETTE, A
    BEAUJEAN, F
    CABANES, PA
    BENHAMOU, E
    HAYAT, M
    BULLETIN DU CANCER, 1990, 77 (02) : 169 - 180
  • [32] HIGH-DOSE BUSULFAN (BU) AND CYCLOPHOSPHAMIDE (CY) AS CONDITIONING REGIMEN IN BONE-MARROW TRANSPLANTATION (BMT)
    QUABECK, K
    BEELEN, DW
    SAYER, H
    GRAEVEN, U
    SCHAEFER, UW
    SCHMIDT, CG
    BLUT, 1987, 55 (04): : 374 - 374
  • [33] HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION SUPPORT IN ADVANCED MALIGNANCIES IN CHILDREN - A PHASE-II STUDY
    HARTMANN, O
    BENHAMOU, E
    BEAUJEAN, F
    PICO, JL
    KALIFA, C
    PATTE, C
    FLAMANT, F
    LEMERLE, J
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (12) : 1804 - 1810
  • [34] HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR THE TREATMENT OF MALIGNANT OVARIAN-TUMORS
    MURAKAMI, M
    SHINOZUKA, T
    KUROSHIMA, Y
    TOKUDA, Y
    TAJIMA, T
    SEMINARS IN ONCOLOGY, 1994, 21 (01) : 29 - 32
  • [35] ESCALATING DOSE OF MITOXANTRONE WITH HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE IN REFRACTORY LYMPHOMA PATIENTS UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    SCHLAIFER, D
    ATTAL, M
    HUGUET, F
    CANAL, P
    LAURENT, G
    PRIS, J
    SEMINARS IN HEMATOLOGY, 1994, 31 (02) : 31 - 31
  • [36] ESCALATING DOSE OF MITOXANTRONE WITH HIGH-DOSE CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE IN PATIENTS WITH REFRACTORY LYMPHOMA UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION
    ATTAL, M
    CANAL, P
    SCHLAIFER, D
    CHATELUT, E
    DEZEUZE, A
    HUGUET, F
    PAYEN, C
    PRIS, J
    LAURENT, G
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (01) : 141 - 148
  • [37] THE ROLE OF HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANT IN CHILDREN WITH MALIGNANCIES
    PHILIP, T
    BONE MARROW TRANSPLANTATION, 1991, 7 : 104 - 105
  • [38] High-dose busulfan and cyclophosphamide followed by autologous bone marrow transplantation and/or peripheral blood progenitor cell rescue for metastatic breast cancer
    Kalaycioglu, ME
    Lichtin, AE
    Andresen, SW
    Tuason, L
    Bolwell, BJ
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (06): : 491 - 494
  • [39] PHARMACOKINETICS OF HIGH-DOSE CYCLOPHOSPHAMIDE FOR BONE-MARROW TRANSPLANTATION
    FASOLA, G
    LOGRECO, P
    CALORI, E
    ZILLI, M
    VERLICCHI, F
    MOTTA, MR
    RICCI, P
    BACCARANI, M
    TURA, S
    HAEMATOLOGICA, 1991, 76 (02) : 120 - 125
  • [40] HIGH-DOSE AMSA AND BONE-MARROW RESCUE IN PATIENTS WITH SOLID TUMORS
    ZANDER, AR
    SPITZER, G
    LEGHA, S
    DICKE, DA
    VERMA, DS
    JOHNSTON, DA
    VELLEKOOP, L
    BERAN, M
    SCHELL, F
    MINNHAAR, G
    BLUMENSCHEIN, GR
    BODEY, GP
    CANCER TREATMENT REPORTS, 1982, 66 (02): : 385 - 386
12345